跳至主要内容
临床试验/2025-524768-39-00
2025-524768-39-00招募中4 期

The pilot bioavailability study comparing the absorption of carbetocin (which is used as prevention of heavy bleeding after childbirth) in PABAL 100 μg/mL Solution for Injection when administered sublingually in the dose of 500 μg and intramuscularly in the dose of 100 μg.

Oxytone Bioscience B.V.1 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2026年2月9日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
4
试验地点
1

研究概览

简要总结

暂无简介。

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
性别
Female
接受健康志愿者
是

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Oxytone Bioscience B.V.
申办方类型
Pharmaceutical company
责任方
Principal Investigator
主要研究者

Yvone van Rijswick

Scientific

Oxytone Bioscience B.V.

研究点 (1)

Loading locations...

相似试验

已完成
1 期
A Phase 1 Study Evaluating Relative Bioavailability of Sprinkled Ritlecitinib in Applesauce, Yoghurt, and Strawberry Jam and Evaluating the Effect of Food on the Bioavailability of Ritlecitinib Intact Blend-In Capsule in Healthy Adult Participants.Alopecia Areata, Rheumatoid Arthritis, Vitiligo, Ulcerative Colitis and Crohn's Disease
2022-502872-22-00Pfizer Inc.12
招募中
1 期
A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy SubjectsCardiomyopathy
NCT07272330Shandong Suncadia Medicine Co., Ltd.38
已完成
1 期
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single dose to healthy subjects under fasting conditions.Healthy volunteers
2024-519661-22-00Farmalider S.A.24
已完成
1 期
A study in healthy people to compare 2 different formulations of nerandomilast tablets when taken with or without foodHealthy volunteer trial
2024-511245-18-00Boehringer Ingelheim International GmbH15
已完成
1 期
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA® 0.1%, gel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy postmenopausal womenNo therapeutic indication in the current trial with healthy volunteers.
2024-517969-16-00CCDRD Cooperative Clinical Drug Research and Development AG, Ioulia And Irene Tseti Pharmaceutical Laboratories S.A.18